JP2025503229A5 - - Google Patents
Info
- Publication number
- JP2025503229A5 JP2025503229A5 JP2024544781A JP2024544781A JP2025503229A5 JP 2025503229 A5 JP2025503229 A5 JP 2025503229A5 JP 2024544781 A JP2024544781 A JP 2024544781A JP 2024544781 A JP2024544781 A JP 2024544781A JP 2025503229 A5 JP2025503229 A5 JP 2025503229A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- sequence
- nos
- acid sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022074078 | 2022-01-26 | ||
| CNPCT/CN2022/074078 | 2022-01-26 | ||
| CN2022110153 | 2022-08-04 | ||
| CNPCT/CN2022/110153 | 2022-08-04 | ||
| CNPCT/CN2022/128951 | 2022-11-01 | ||
| CN2022128951 | 2022-11-01 | ||
| PCT/CN2023/073039 WO2023143343A1 (en) | 2022-01-26 | 2023-01-19 | Anti-her2/trop2 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503229A JP2025503229A (ja) | 2025-01-30 |
| JP2025503229A5 true JP2025503229A5 (cg-RX-API-DMAC7.html) | 2026-01-29 |
Family
ID=87470782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544781A Pending JP2025503229A (ja) | 2022-01-26 | 2023-01-19 | 抗her2/trop2抗体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250059297A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4469485A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025503229A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240135654A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118804932A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023210951A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3246716A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024009292A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023143343A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111655295B (zh) | 2018-08-29 | 2024-05-28 | 荣昌生物制药(烟台)股份有限公司 | 抗her2抗体药物偶联物在治疗尿路上皮癌中的用途 |
| WO2024046455A1 (en) * | 2022-09-01 | 2024-03-07 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Methods for preparing antibody-drug conjugates |
| EP4761766A1 (en) * | 2023-08-14 | 2026-06-24 | Seagen Inc. | Methods of treating cancer using anti-her2 antibody-drug conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201902571VA (en) * | 2013-12-25 | 2019-04-29 | Daiichi Sankyo Co Ltd | Anti-trop2 antibody-drug conjugate |
| EP3286224A4 (en) * | 2015-04-22 | 2018-11-14 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells |
| US10689458B2 (en) * | 2015-11-30 | 2020-06-23 | Pfizer Inc. | Site specific HER2 antibody drug conjugates |
| SG10201913263SA (en) * | 2016-09-29 | 2020-03-30 | Beijing Hanmi Pharmaceutical Co Ltd | Heterodimeric immunoglobulin constructs and preparation methods thereof |
| CA3049791A1 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| WO2019222428A1 (en) * | 2018-05-16 | 2019-11-21 | Arbele Limited | Composition of bispecific antibodies and method of use thereof |
| EP3906055A4 (en) * | 2019-01-04 | 2023-01-04 | Trio Pharmaceuticals, Inc. | MULTISPECIFIC PROTEIN MOLECULES AND THEIR USES |
| CN115667532A (zh) * | 2020-06-02 | 2023-01-31 | 百奥赛图(北京)医药科技股份有限公司 | 具有共有轻链免疫球蛋白基因座的经遗传修饰的非人动物 |
| US20240101717A1 (en) * | 2021-01-22 | 2024-03-28 | Bionecure Therapeutics, Inc. | Anti-her-2/trop-2 constructs and uses thereof |
-
2023
- 2023-01-19 AU AU2023210951A patent/AU2023210951A1/en active Pending
- 2023-01-19 CN CN202380018745.8A patent/CN118804932A/zh active Pending
- 2023-01-19 KR KR1020247027448A patent/KR20240135654A/ko active Pending
- 2023-01-19 EP EP23746224.7A patent/EP4469485A4/en active Pending
- 2023-01-19 WO PCT/CN2023/073039 patent/WO2023143343A1/en not_active Ceased
- 2023-01-19 JP JP2024544781A patent/JP2025503229A/ja active Pending
- 2023-01-19 US US18/724,021 patent/US20250059297A1/en active Pending
- 2023-01-19 CA CA3246716A patent/CA3246716A1/en active Pending
- 2023-01-19 MX MX2024009292A patent/MX2024009292A/es unknown